Xinhua Silk Road: Ex-champ Bruno Hasulyo starts new career to bolster SUP in eastern China metropolis
BEIJING, Oct. 4, 2024 /PRNewswire/ -- Born in Hungary, Bruno Hasulyo is not just a professional athlete but also an adventurer at heart and a visionary entrepreneur. His life journey has been driven by a singular goal -- becoming an iconic figure in the world of stand-up paddling (SUP) and ushering in a new era for the sport where it gets more accessible to everyone. Bruno's...
Siriraj Enhances Diagnostic Capabilities, a Crucial Factor for Medical Care
BANGKOK, Oct. 4, 2024 /PRNewswire/ -- Siriraj Hospital excels in maintaining its high standards for every service, including diagnostics through the integration of cutting-edge technology into its medical services, furthering its mission to become a global leader in healthcare. The hospital is focused on expanding its diagnostic expertise across all specialties and strategically uses artificial intelligence (AI) to boost...
Agilent and National University of Singapore Launch Center of Excellence in Cell Metabolism to Improve Population Health
Center will enable targeted and untargeted metabolic profiling for population-based large-scale cohorts across translational research SINGAPORE, Oct. 4, 2024 /PRNewswire/ -- Agilent Technologies Inc. (NYSE: A) today announced a new strategic partnership with National University of Singapore (NUS), acting through the Yong Loo Lin School of Medicine (NUS Medicine), to establish the NUS-Agilent...
First Patient Dosed in Phase II ‘CA-NINE’ Trial of TLX250-CDx for Detection of Recurrent Kidney Cancer After Surgery
MELBOURNE, Australia, Oct. 4, 2024 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that the first patient has been dosed in a Phase II trial exploring the clinical utility of Telix's first-in-class investigational PET agent, TLX250-CDx (89Zr-girentuximab) in recurrent clear cell renal cell carcinoma (ccRCC) after surgery. 'CA-NINE'...
IBC launches RadSep, Inc.: Best-in-class, highly selective separations using Molecular Recognition Technology™ (MRT™) for production of critical radioisotopes essential to cancer therapies
Best-in-class, highly selective separations technology for the radiopharmaceuticals industry Exhibitor at the European Association of Nuclear Medicine (EANM) Congress in Hamburg, Germany 20-23 October 2024 at Booth S14 (Exhibition Hall 3) Over 36 years of experience with first generation flowsheets for highly selective separation of radium (Ra), lead (Pb),...
WELLlife COVID-19/Influenza A&B Home Test on Sale for Amazon Prime Day
Standfirst: Welllife, a Flu home test in addition to COVID-19 BOLINGBROOK, Ill., Oct. 3, 2024 /PRNewswire/ -- WELLlife, a leading innovator in medical diagnostic and testing solutions, is increasing accessibility to respiratory illness testing this flu season. The WELLlife COVID-19/Influenza A&B Home Test will be on sale for $22.98/box during the Amazon Prime Day event, from Oct. 8 to...
The Exosome Production Method Patent by Panacell Biotech Registered as Original Technology
SEOUL, South Korea, Oct. 3, 2024 /PRNewswire/ -- Panacell Biotech Co., Ltd. (Panacell Biotech) announced that the patent related to their exosome manufacturing method filed last year was registered as a core technology in the patent registry on August 7, 2024, following the Patent Act. Panacell Biotech, whose Chief Executive Officer (CEO) is Dr. Seung Ho Choi, is a research institute...
Veritas Genetic participates in a groundbreaking study highlighting the importance of polygenic risk scores in the clinical management of breast cancer patients
The study, conducted in collaboration with the Department of Biomedicine and Prevention at the University of Rome Tor Vergata and Tor Vergata University Hospital, underscores the relevance of polygenic risk scores (PRS) in risk stratification for patients with a genetic predisposition to breast cancer. MADRID, Oct. 3, 2024 /PRNewswire/ -- Veritas Genetics, in collaboration with the Department of...
CNN’s ‘Tomorrow Transformed’ explores how the future of healthcare is connecting lives
HONG KONG, Oct. 3, 2024 /PRNewswire/ -- Since the dawn of healthcare, technology has been drastically improving medical systems and services to help us live longer and better lives. In this special half-hour episode of 'Tomorrow Transformed', connections, partnerships, and collaborations in the world of medicine are humanized through compelling first-person stories....
A*STAR and Flagship Pioneering Announce Partnership to Spur Biotech Innovation in Singapore
Organizations Plan to Jointly Advance Breakthrough Solutions in Human Health and Sustainability, Drive Research Collaboration, Entrepreneurship and Accelerate Talent Development SINGAPORE, Oct. 3, 2024 /PRNewswire/ -- The Agency for Science, Technology and Research (A*STAR), Singapore's lead public sector R&D agency, and Flagship Pioneering, the bioplatform innovation company, today announced plans to collaborate to...
